Clinical Trials Logo

Endometrioma clinical trials

View clinical trials related to Endometrioma.

Filter by:

NCT ID: NCT01982526 Completed - Surgery Clinical Trials

Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients

Start date: May 2012
Phase:
Study type: Observational [Patient Registry]

Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.

NCT ID: NCT01942122 Completed - Endometrioma Clinical Trials

DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis

Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

This is a 3-arm, prospective, randomized, double-blind, and controlled study of DLBS1442 for the treatment of pain in patients suspected endometriosis. It is hypothesized that the reduction of the composite-pain intensity (as measured by VAS) from baseline to the end of study (week 8th) resulting from administration of DLBS1442, regardless of the dosage regimen, is significantly greater than that of Control. In addition, the administration of DLBS1442 at higher dose also results in significantly greater reduction than that of DLBS1442 at lower dose and of Control.

NCT ID: NCT01808170 Completed - Endometrioma Clinical Trials

Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve

Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of laparoscopic ovarian cystectomy versus laparoscopic cyst deroofing on ovarian reserve measured by serum levels of anti mullerian hormone and antral follicle count in patients with endometriomas.

NCT ID: NCT01268930 Completed - Endometrioma Clinical Trials

Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas

Start date: September 2010
Phase: N/A
Study type: Interventional

In this study, impacts of hemostatic matrix and bipolar electrocoagulation on ovarian reserve in women undergoing ovarian endometrioma excision are compared.

NCT ID: NCT00999479 Withdrawn - Endometrioma Clinical Trials

Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation

Start date: October 2009
Phase: N/A
Study type: Interventional

The aim of this study is to determine whether or not continuous combined oral contraceptive pills (COCP's) decrease the risk of recurrent endometrioma formation. The investigators' hypothesis is that patients who have endometriomas surgically removed and then are started on COCP's will have a decreased incidence of recurrent endometrioma formation. The investigators' research protocol is designed to show a statistically significant decreased incidence of endometrioma formation in the hopes that physicians will use COCP's in patients they have removed an endometrioma in who do not desire immediate fertility. Long term, the investigators hope to establish a standard of care that COCP's be used postoperatively in appropriate candidates to decrease the chance of recurrent endometrioma formation.